Detalles de la búsqueda
1.
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic.
Gut;
72(2): 295-305, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35902214
2.
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities.
Gastroenterology;
162(5): 1456-1475.e1, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101422
3.
Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn's Disease.
Clin Gastroenterol Hepatol;
21(11): 2918-2927.e6, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37004971
4.
Fine-mapping inflammatory bowel disease loci to single-variant resolution.
Nature;
547(7662): 173-178, 2017 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28658209
5.
Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies.
Clin Gastroenterol Hepatol;
20(8): 1671-1686.e16, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33933376
6.
The Global Incidence of Peptic Ulcer Disease Is Decreasing Since the Turn of the 21st Century: A Study of the Organisation for Economic Co-Operation and Development (OECD).
Am J Gastroenterol;
117(9): 1419-1427, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973143
7.
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.
Gut;
70(10): 1884-1893, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903149
8.
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Gut;
70(5): 865-875, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33753421
9.
Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn's Disease.
Clin Gastroenterol Hepatol;
19(9): 1835-1844.e6, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32798706
10.
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
Gastroenterology;
158(1): 189-199, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31600487
11.
Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort.
J Gastroenterol Hepatol;
36(8): 2067-2075, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33381875
12.
Analysis of colectomy rates for ulcerative colitis in pre- and postbiological eras in Lothian, Scotland.
Colorectal Dis;
23(5): 1175-1183, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33350054
13.
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel.
Gut;
69(10): 1769-1777, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32513653
14.
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.
Gut;
69(6): 984-990, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303607
15.
Paediatric Patients (Less Than Age of 17 Years) Account for Less Than 1.5% of All Prevalent Inflammatory Bowel Disease Cases.
J Pediatr Gastroenterol Nutr;
71(4): 521-523, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32639452
16.
IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology.
Gut;
68(11): 1953-1960, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31300515
17.
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research.
Gut;
73(2): 379-383, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36754608
18.
Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease.
Clin Gastroenterol Hepatol;
17(11): 2269-2276.e4, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30772585
19.
Implementation of CT-P13 via a Managed Switch Programme in Crohn's Disease: 12-Month Real-World Outcomes.
Dig Dis Sci;
64(6): 1660-1667, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30535885
20.
Withdrawal of the British Society of Gastroenterology IBD risk grid for COVID-19 severity.
Gut;
72(2): 410-412, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35512822